Future development and use of mRNA-based vaccines must consider impact on innate immunity.
Renowned researcher Donna L. Farber, PhD of the Columbia Center for Translational Immunology brings us up-to-date on current knowledge about the virus and shares her insights on what this means for ongoing management. Webinar recorded on January 20, 2021.
Articles: https://www.i24news.tv/en Live:http://i24ne.ws/4GMK30qJn0A Facebook: https://www.facebook.com/i24newsEN/ Twitter: https://twitter.com/i24NEWS_EN Instagram: https://www.instagram.com/i24news/ #i24NEWS #Coronavirus i24NEWS DESK |